Medicare’s Hospital Value-Based Purchasing program has not accelerated the improvement of patient experience beyond previous trends, according to a study reported this week in Health Affairs. “Instead, we found that the rate of improvements in patient experience has slowed since the program was implemented,” the authors said. “Over the entire study period, certain subsets of hospitals (such as small ones) seemed to have improved in patient experience more than other subsets (such as larger hospitals), yet even for the institutions that had greater improvement, the majority of the change occurred before implementation of the VBP program.” The study examined trends in multiple measures of patient satisfaction between 2008 and 2014. The Centers for Medicare & Medicaid Services began publicly reporting on patient-reported experience through the Hospital Consumer Assessment of Healthcare Providers and Systems survey in 2008, and tied Medicare payments directly to these measures through the VBP program in 2011. The authors said the study “adds to a growing body of literature suggesting that U.S. pay-for-performance schemes have had little to no effect on driving meaningful improvements in other patient outcomes.”

Related News Articles

Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…
Blog
Public
Cross-industry insights and new technology are helping HCA Healthcare reduce risk, improve outcomes and lead the future of high-reliability careFor Randy Fagin…
Headline
Medicare open enrollment for 2026 began Oct. 15 and runs through Dec. 7. During the annual enrollment period, Medicare-eligible individuals can check their…
Headline
The Food and Drug Administration has identified a Class I recall of Abiomed Automated Impella Controllers due to the potential for serious injury or death. The…